Symrise AG Logo

Symrise AG

SY1.DE

(2.5)
Stock Price

119,90 EUR

5.73% ROA

9.53% ROE

48.68x PER

Market Cap.

13.630.565.440,00 EUR

71.73% DER

1.08% Yield

7.2% NPM

Symrise AG Stock Analysis

Symrise AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Symrise AG Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

2 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

3 ROE

The stock's ROE falls within an average range (8.31%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (5.73%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 DER

The stock has a reasonable amount of debt compared to its ownership (72%), suggesting a balanced financial position and a moderate level of risk.

6 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

7 Dividend Growth

The company's dividend growth has shown a positive trajectory over the past three years, consistently increasing year after year, indicating a favorable trend for potential investors.

8 Buffet Intrinsic Value

The company's stock seems undervalued (1.603) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

9 PBV

The stock's high Price-to-Book Value (P/BV) ratio (3.82x) suggests it's overvalued, potentially making it an expensive investment.

10 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

11 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

Symrise AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Symrise AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Symrise AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Symrise AG Revenue
Year Revenue Growth
2005 1.148.919.000
2006 1.229.421.000 6.55%
2007 1.274.458.000 3.53%
2008 1.319.862.000 3.44%
2009 1.361.954.000 3.09%
2010 1.571.890.000 13.36%
2011 1.583.647.000 0.74%
2012 1.734.934.000 8.72%
2013 1.830.386.000 5.21%
2014 2.120.107.000 13.67%
2015 2.601.730.000 18.51%
2016 2.903.187.000 10.38%
2017 2.996.294.000 3.11%
2018 0 0%
2019 3.407.854.000 100%
2020 3.520.451.000 3.2%
2021 3.825.691.000 7.98%
2022 4.618.476.000 17.17%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Symrise AG Research and Development Expenses
Year Research and Development Expenses Growth
2005 -87.750.000
2006 -78.022.000 -12.47%
2007 -82.252.000 5.14%
2008 86.185.000 195.44%
2009 95.686.000 9.93%
2010 107.859.000 11.29%
2011 107.593.000 -0.25%
2012 113.780.000 5.44%
2013 126.995.000 10.41%
2014 139.350.000 8.87%
2015 169.640.000 17.86%
2016 186.152.000 8.87%
2017 196.432.000 5.23%
2018 0 0%
2019 213.349.000 100%
2020 212.297.000 -0.5%
2021 220.742.000 3.83%
2022 254.487.000 13.26%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Symrise AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 74.155.000 100%
2009 81.458.000 8.97%
2010 83.177.000 2.07%
2011 76.849.000 -8.23%
2012 80.760.000 4.84%
2013 85.028.000 5.02%
2014 120.280.000 29.31%
2015 148.484.000 18.99%
2016 158.492.000 6.31%
2017 154.658.000 -2.48%
2018 0 0%
2019 200.984.000 100%
2020 203.194.000 1.09%
2021 220.995.000 8.05%
2022 257.915.000 14.31%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Symrise AG EBITDA
Year EBITDA Growth
2005 1.086.451.000
2006 1.082.650.000 -0.35%
2007 1.085.948.000 0.3%
2008 268.142.000 -304.99%
2009 264.452.000 -1.4%
2010 343.377.000 22.98%
2011 317.916.000 -8.01%
2012 338.399.000 6.05%
2013 366.994.000 7.79%
2014 430.044.000 14.66%
2015 573.372.000 25%
2016 609.113.000 5.87%
2017 623.612.000 2.33%
2018 0 0%
2019 696.476.000 100%
2020 735.958.000 5.36%
2021 830.533.000 11.39%
2022 859.093.000 3.32%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Symrise AG Gross Profit
Year Gross Profit Growth
2005 1.821.431.000
2006 1.941.912.000 6.2%
2007 1.988.159.000 2.33%
2008 557.485.000 -256.63%
2009 557.924.000 0.08%
2010 681.708.000 18.16%
2011 653.604.000 -4.3%
2012 700.555.000 6.7%
2013 770.838.000 9.12%
2014 888.403.000 13.23%
2015 1.111.589.000 20.08%
2016 1.185.469.000 6.23%
2017 1.224.469.000 3.19%
2018 0 0%
2019 1.367.079.000 100%
2020 1.390.478.000 1.68%
2021 1.478.831.000 5.97%
2022 1.702.076.000 13.12%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Symrise AG Net Profit
Year Net Profit Growth
2005 -52.406.000
2006 -89.848.000 41.67%
2007 97.436.000 192.21%
2008 90.386.000 -7.8%
2009 84.349.000 -7.16%
2010 133.500.000 36.82%
2011 146.535.000 8.9%
2012 157.492.000 6.96%
2013 172.335.000 8.61%
2014 185.000.000 6.85%
2015 246.778.000 25.03%
2016 252.710.000 2.35%
2017 270.270.000 6.5%
2018 0 0%
2019 298.308.000 100%
2020 306.873.000 2.79%
2021 374.924.000 18.15%
2022 280.007.000 -33.9%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Symrise AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 -1
2006 -1 0%
2007 1 0%
2008 1 0%
2009 1 0%
2010 1 100%
2011 1 0%
2012 1 0%
2013 1 0%
2014 1 0%
2015 2 0%
2016 2 0%
2017 2 50%
2018 0 0%
2019 2 100%
2020 2 0%
2021 3 0%
2022 2 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Symrise AG Free Cashflow
Year Free Cashflow Growth
2005 20.222.000
2006 -27.892.000 172.5%
2007 140.631.000 119.83%
2008 100.565.000 -39.84%
2009 169.017.000 40.5%
2010 164.554.000 -2.71%
2011 143.683.000 -14.53%
2012 152.060.000 5.51%
2013 204.668.000 25.7%
2014 251.645.000 18.67%
2015 242.464.000 -3.79%
2016 65.858.000 -268.16%
2017 193.017.000 65.88%
2018 213.661.000 9.66%
2019 372.361.000 42.62%
2020 491.640.000 24.26%
2021 347.400.000 -41.52%
2022 109.940.000 -215.99%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Symrise AG Operating Cashflow
Year Operating Cashflow Growth
2005 20.222.000
2006 -27.892.000 172.5%
2007 140.631.000 119.83%
2008 153.098.000 8.14%
2009 225.690.000 32.16%
2010 235.075.000 3.99%
2011 200.908.000 -17.01%
2012 219.503.000 8.47%
2013 274.784.000 20.12%
2014 343.214.000 19.94%
2015 375.179.000 8.52%
2016 120.335.000 -211.78%
2017 396.184.000 69.63%
2018 441.785.000 10.32%
2019 546.766.000 19.2%
2020 635.681.000 13.99%
2021 521.556.000 -21.88%
2022 360.109.000 -44.83%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Symrise AG Capital Expenditure
Year Capital Expenditure Growth
2005 0
2006 0 0%
2007 0 0%
2008 52.533.000 100%
2009 56.673.000 7.31%
2010 70.521.000 19.64%
2011 57.225.000 -23.23%
2012 67.443.000 15.15%
2013 70.116.000 3.81%
2014 91.569.000 23.43%
2015 132.715.000 31%
2016 54.477.000 -143.62%
2017 203.167.000 73.19%
2018 228.124.000 10.94%
2019 174.405.000 -30.8%
2020 144.041.000 -21.08%
2021 174.156.000 17.29%
2022 250.169.000 30.38%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Symrise AG Equity
Year Equity Growth
2005 25.733.000
2006 550.641.000 95.33%
2007 642.713.000 14.33%
2008 648.395.000 0.88%
2009 688.964.000 5.89%
2010 842.117.000 18.19%
2011 913.735.000 7.84%
2012 876.623.000 -4.23%
2013 951.063.000 7.83%
2014 1.414.193.000 32.75%
2015 1.568.332.000 9.83%
2016 1.672.044.000 6.2%
2017 1.712.746.000 2.38%
2018 1.944.408.000 11.91%
2019 2.464.433.000 21.1%
2020 2.361.661.000 -4.35%
2021 3.252.259.000 27.38%
2022 3.610.431.000 9.92%
2023 3.567.414.000 -1.21%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Symrise AG Assets
Year Assets Growth
2005 1.792.178.944
2006 1.803.137.024 0.61%
2007 1.790.923.008 -0.68%
2008 1.890.679.000 5.28%
2009 1.895.231.000 0.24%
2010 2.058.998.000 7.95%
2011 2.098.176.000 1.87%
2012 2.151.884.000 2.5%
2013 2.210.422.000 2.65%
2014 3.999.836.000 44.74%
2015 4.183.832.000 4.4%
2016 4.752.847.000 11.97%
2017 4.674.621.000 -1.67%
2018 4.920.379.000 4.99%
2019 5.957.209.000 17.4%
2020 5.939.769.000 -0.29%
2021 6.642.738.000 10.58%
2022 7.782.963.000 14.65%
2023 7.870.958.000 1.12%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Symrise AG Liabilities
Year Liabilities Growth
2005 1.766.445.944
2006 1.252.496.024 -41.03%
2007 1.148.210.008 -9.08%
2008 1.242.284.000 7.57%
2009 1.206.267.000 -2.99%
2010 1.216.881.000 0.87%
2011 1.184.441.000 -2.74%
2012 1.275.261.000 7.12%
2013 1.259.359.000 -1.26%
2014 2.567.663.000 50.95%
2015 2.595.597.000 1.08%
2016 3.020.673.000 14.07%
2017 2.905.285.000 -3.97%
2018 2.975.971.000 2.38%
2019 3.492.776.000 14.8%
2020 3.578.108.000 2.38%
2021 3.390.479.000 -5.53%
2022 4.172.532.000 18.74%
2023 4.303.544.000 3.04%

Symrise AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
33.04
Net Income per Share
2
Price to Earning Ratio
48.68x
Price To Sales Ratio
2.95x
POCF Ratio
37.85
PFCF Ratio
123.98
Price to Book Ratio
3.84
EV to Sales
3.43
EV Over EBITDA
18.46
EV to Operating CashFlow
44.05
EV to FreeCashFlow
144.29
Earnings Yield
0.02
FreeCashFlow Yield
0.01
Market Cap
13,63 Bil.
Enterprise Value
15,86 Bil.
Graham Number
33.84
Graham NetNet
-22.85

Income Statement Metrics

Net Income per Share
2
Income Quality
1.24
ROE
0.08
Return On Assets
0.04
Return On Capital Employed
0.07
Net Income per EBT
0.75
EBT Per Ebit
0.96
Ebit per Revenue
0.1
Effective Tax Rate
0.26

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0.06
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.36
Operating Profit Margin
0.1
Pretax Profit Margin
0.1
Net Profit Margin
0.07

Dividends

Dividend Yield
0.01
Dividend Yield %
1.08
Payout Ratio
0.51
Dividend Per Share
1.05

Operating Metrics

Operating Cashflow per Share
2.58
Free CashFlow per Share
0.79
Capex to Operating CashFlow
-0.69
Capex to Revenue
-0.05
Capex to Depreciation
-0.86
Return on Invested Capital
0.05
Return on Tangible Assets
0.06
Days Sales Outstanding
0
Days Payables Outstanding
66.28
Days of Inventory on Hand
166.15
Receivables Turnover
0
Payables Turnover
5.51
Inventory Turnover
2.2
Capex per Share
-1.79

Balance Sheet

Cash per Share
2,25
Book Value per Share
25,41
Tangible Book Value per Share
5.08
Shareholders Equity per Share
25.41
Interest Debt per Share
18.65
Debt to Equity
0.72
Debt to Assets
0.33
Net Debt to EBITDA
2.6
Current Ratio
2.76
Tangible Asset Value
0,71 Bil.
Net Current Asset Value
-1,49 Bil.
Invested Capital
0.72
Working Capital
1,71 Bil.
Intangibles to Total Assets
0.37
Average Receivables
0,00 Bil.
Average Payables
0,47 Bil.
Average Inventory
1157760000
Debt to Market Cap
0.19

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Symrise AG Dividends
Year Dividends Growth
2008 1
2009 1 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 0%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 2 100%
2021 1 0%
2022 1 100%
2023 1 0%

Symrise AG Profile

About Symrise AG

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, aroma molecules, cosmetic ingredients, and mint flavors, as well as specific application processes for such substances. This segment's products are used by manufacturers of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. It operates in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. Symrise AG was founded in 1874 and is headquartered in Holzminden, Germany.

CEO
Dr. Heinz-Jurgen Bertram Ph.D
Employee
12.656
Address
MUehlenfeldstrasse 1
Holzminden, 37603

Symrise AG Executives & BODs

Symrise AG Executives & BODs
# Name Age
1 Dr. Jurgen Nienhaus
Corporate Vice President of Operations
70
2 Dr. Jean-Yves Parisot
Head of Taste, Nutrition & Health Segment and Member of Executive Board
70
3 Dr. Stephanie Cossmann
Member of Executive Board & Labour Director
70
4 Dr. Jorn Andreas
President of Scent & Care Segment and Member of Executive Board
70
5 Mr. Roberto Ascoli
Senior Vice President of New Business Development - Scent & Care Division
70
6 Mr. Arnaud Bellon
Senior Vice President and Global Head of Botanicals & Colors - The Cosmetic Ingredients Division
70
7 Mr. Tobias Erfurth
Head of Investor Relation
70
8 Ms. Marie-Laure Roumiguiere
Head of Global Account Management of EAME - Cosmetic Ingredients Division
70
9 Mr. Olaf Klinger
Chief Financial Officer, Head of Finance, Legal & IT Department and Member of Executive Board
70
10 Dr. Heinz-Jurgen Bertram Ph.D.
Chief Executive Officer, Chairman of Executive Board & Labour Director
70

Symrise AG Competitors

Brenntag SE Logo
Brenntag SE

BNR.DE

(3.0)
MTU Aero Engines AG Logo
MTU Aero Engines AG

MTX.DE

(3.0)
Hannover Rück SE Logo
Hannover Rück SE

HNR1.DE

(2.8)